Abstract
Glycan structures on the cell surface are altered in various human diseases and disorders. These changes are, in most cases, associated with aberrant changes in glycosyltransferase expression. The activities of glycosyltransferases are controlled by several mechanisms, including the regulation of the expression of their transcripts. Many studies have revealed the important role of transcription factors in the transcriptional regulation of glycosyltransferases that are involved in the regulation of glycans on several types of glycoconjugates. Addressing the regulatory role of transcription factors not only sheds considerable light on the molecular mechanisms underlying the glycosyltransferase gene regulation but also provides a solid foundation for understanding the potential contribution of transcription factor-mediated regulation to particular diseases and identifying potential, novel targets for therapeutic intervention. In this chapter, the regulation of glycans, in particular N- and O-linked glycoprotein glycans, by transcription factors is summarized and a perspective on this regulation is presented.
Access provided by Autonomous University of Puebla. Download reference work entry PDF
Similar content being viewed by others
Keywords
- Transcription factors
- Glycosyltransferase gene regulation
- Promoter
- Epigenetically
- Post-transcriptional
- cis-elements
Introduction
Protein glycosylation is the most prevalent and complex posttranslational modification (Varki 1993). Glycan structures associated with proteins and lipids have been shown to regulate numerous biological and physiological events, such as protein folding and quality control, protein function and signaling, protein half-life and endocytosis, cell-cell interaction, autoimmunity, hormone bioactivity, gene expression, tumor metastasis, and many others (Moremen et al. 2012; Varki 1993). Most glycans on membrane and secreted proteins can be classified into two major types based on their linkage to polypeptide structures: N-linked glycans and O-linked glycans. Glycans attached to Asn side chains of polypeptides form N-linked glycans, while O-glycosylation is initiated by the addition of O-linked N-acetylglucosamine (GalNAc) to serine or threonine, catalyzed by a family of polypeptide N-acetylgalactosaminyltransferases (ppGalNAcT) enzymes. In addition to O-linked GalNAc, commonly referred to as mucin-type O-glycosylation, additional, distinct glycan types linked to Ser or Thr with defined functions have been identified, including O-mannose,O-Fuc, and O-GlcNAc (Moremen et al. 2012). Glycan structures on glycoproteins are complex with a great diversity for branching and anomeric linkages. Although the biosynthesis of the polypeptides of glycoproteins is controlled by the transcription and translation of their corresponding genes, the posttranslational glycosylation of these glycoproteins is not template driven. Instead, hundreds of proteins are involved in the biosynthesis of the various kinds of glycan structures. Among these, about 250 open reading frames in the mouse and human genomes are identified as glycosyltransferases, the enzymes that catalyze the addition of glycans to polypeptides using nucleotide or lipid-linked sugars as activated donor substrate. Therefore, the expression levels of glycans on glycoconjugates are determined primarily by the activities of corresponding glycosyltransferases. The transcripts and expression of glycosyltransferases are regulated during embryonic development, cellular differentiation, and proliferation. Aberrant expression of these enzymes results in aberrant glycans, which have been associated with a wide range of human diseases, including tumor, diabetes, cardiovascular, immunological, infectious, and congenital disorders (Marth and Grewal 2008).
The expression of glycosyltransferases is controlled by many biological effectors, including the Golgi complex itself, which can regulate the function of glycosyltransferases, and various transcriptional regulators that control glycosyltransferase gene expression, such as the binding of transcription factors to promoter regions, as well as epigenetic regulation. Transcription factors are a group of proteins that recognize and bind to a segment of DNA in the promoter and/or enhancer region, recruiting cofactors and RNA polymerase II and regulating the expression of specific genes (Lee and Young 2013; Spitz and Furlong 2012). There are two different types of transcription factors based on their regulatory responsibilities, those that control initiation and those that control elongation. Most transcription factors are believed to control transcription initiation by recruiting co-activators, such as the Mediator complex, P300, and general transcription factors (Juven-Gershon and Kadonaga 2010; Lee and Young 2013; Taatjes 2010). Gene regulation by transcription factors plays a pivotal role in many cell events, and several human diseases and syndromes have been linked to the mutations in transcription factors, including diabetes, cardiovascular diseases, autoimmunity, and certain cancers (Lee and Young 2013).
Regulation of Glycans by Transcription Factors
Many studies have investigated the transcriptional regulation of glycosyltransferase gene expression by transcription factors using various strategies, such as rapid amplification of 5′ cDNA ends (5′ RACE), luciferase reporter assays, series deletion of promoter regions, site-directed mutagenesis, electrophoretic mobility shift assays (EMSA), and chromatin immunoprecipitation (ChIP) assays. Results show that the expression of glycosyltransferases associated with the initiation, extension, branching, and modification of both N- and O-linked glycans are regulated by transcription factors in a tissue- or cell-specific manner. The types of transcription factors involved in this regulation vary from the common families of transcription factors, such as Ets and AP-2, to some differentiation inducers and cytokines that directly bind to cis-regulatory elements in flanking sequences of glycosyltransferase genes, such as ATRA and IL13. The binding of transcription factors to promoter regions influences either positively or negatively the transcription of specific genes. Table 1 summarizes the involvement of transcription factors in the regulation of the expression of particular glycosyltransferases.
Perspective
A study that cataloged changes of glycosyltransferase transcript expression, as well as changes in glycan structures, during mouse embryonic stem cell differentiation also compared these two sets of data to determine the degree to which the changes were associated (Nairn et al. 2012). The conclusion was that in by far the majority of cases, there was a positive association between changes in a particular glycosyltransferase transcript and the changes in glycan expression whose levels these enzymes should impact. This result suggests that the most common mechanism for regulation of glycan expression is due to changes in glycosyltransferase transcript expression. There were, however, a significant number of cases where there were changes in a transcript but no corresponding change in the glycan products synthesized by the enzyme encoded by the transcript, or vice versa, there were no changes in transcripts but there were observed changes in corresponding glycan products attributed to the enzyme encoded by these transcripts. These intriguing examples demonstrate not only that transcript expression is only one of many regulatory mechanisms for glycan expression but also that our understanding of these mechanisms is very incomplete. A study of some of these examples may, therefore, allow us to identify additional regulatory mechanisms for glycan expression. It is also clear that the expression of at least one glycosyltransferase is regulated epigenetically (Kizuka et al. 2011). Presently, the precise mechanisms that regulate glycosyltransferase transcripts have only been studied in detail for about two dozen enzymes (Table I). As more and more functions for specific glycan structures are discovered and the mechanisms by which their expression become relevant, this list of enzymes and the relevant transcription factors in play will undoubtedly grow. Some glycosyltransferase transcripts have extensive 3′-untranslated regions; therefore, it is quite likely that there is control of glycosyltransferase expression by posttranscriptional mechanisms , as well.
Further studies are needed to elucidate precisely how expression of glycosyltransferases is controlled by transcription factors in specific tissues and cell types. Since many diseases and syndromes are associated with mutations in both transcription factors and regulatory regions of promoters (Lee and Young 2013), analyses of genetic variations in transcription factors and regulatory regions of glycosyltransferase genes will likely define a research direction for the study of the transcriptional regulation of glycans expression. Indeed, mutations in the cis-elements of promoter regions of glycosyltransferases, leading to the generation of additional binding sites for certain transcription factors, have been reported recently (Raducu et al. 2012).
References
Buckhaults P, Chen L, Fregien N et al (1997) Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem 272:19575–19581
Dabrowska A, Baczynska D, Widerak K et al (2005) Promoter analysis of the human alpha1,3/4-fucosyltransferase gene (FUT III). Biochim Biophys Acta 1731:66–73
Falkenberg VR, Fregien N (2007) Control of core 2 beta1,6 N-acetylglucosaminyltransferase-I transcription by Sp1 in lymphocytes and epithelial cells. Glycoconj J 24:511–519
Higai K, Ishihara S, Matsumoto K (2006) NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol Pharm Bull 29:2372–2377
Higai K, Miyazaki N, Azuma Y et al (2008) Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells. Glycoconj J 25:225–235
Isshiki S, Kudo T, Nishihara S et al (2003) Lewis type 1 antigen synthase (beta3Gal-T5) is transcriptionally regulated by homeoproteins. J Biol Chem 278:36611–36620
Izumi H, Ohta R, Nagatani G et al (2003) p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene. Biochem J 373:713–722
Jiang J, Wei Y, Shen J et al (2007) Functional interaction of E1AF and Sp1 in glioma invasion. Mol Cell Biol 27:8770–8782
Juven-Gershon T, Kadonaga JT (2010) Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol 339:225–229
Kang NY, Park YD, Choi HJ et al (2004) Regulatory elements involved in transcription of the human NeuAcalpha2,3Galbeta1,3GalNAcalpha2,6-sialyltransferase (hST6GalNAc IV) gene. Mol Cells 18:157–162
Kang R, Saito H, Ihara Y et al (1996) Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271:26706–26712
Kizuka Y, Kitazume S, Yoshida M et al (2011) Brain-specific expression of N-acetylglucosaminyltransferase IX (GnT-IX) is regulated by epigenetic histone modifications. J Biol Chem 286:31875–31884
Lauc G, Essafi A, Huffman JE et al (2010) Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet 6:e1001256
Lee TI, Young RA (2013) Transcriptional regulation and its misregulation in disease. Cell 152:1237–1251
Lehoux S, Groux-Degroote S, Cazet A et al (2010) Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells. Glycoconj J 27:99–114
Marth JD, Grewal PK (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8:874–887
Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13:448–462
Nairn AV, Aoki K, dela Rosa M et al (2012) Regulation of glycan structures in murine embryonic stem cells: combined transcript profiling of glycan-related genes and glycan structural analysis. J Biol Chem 287:37835–37856
Nomoto M, Izumi H, Ise T et al (1999) Structural basis for the regulation of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res 59:6214–6222
Ohtsubo K, Chen MZ, Olefsky JM et al (2011) Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 17:1067–1075
Raducu M, Baets J, Fano O et al (2012) Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O. Eur J Hum Genet 20:945–952
Sato T, Furukawa K (2004) Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. J Biol Chem 279:39574–39583
Sato T, Furukawa K (2007) Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells. The J Biol Chem 282:27702–27712
Sengupta PK, Bouchie MP, Kukuruzinska MA (2010) N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway. J Biol Chem 285:31164–31173
Spitz F, Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13:613–626
Svensson EC, Soreghan B, Paulson JC (1990) Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation. J Biol Chem 265:20863–20868
Taatjes DJ (2010) The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci 35:315–322
Takashima S, Kurosawa N, Tachida Y et al (2000) Comparative analysis of the genomic structures and promoter activities of mouse Siaalpha2,3Galbeta1,3GalNAc GalNAcalpha2, 6-sialyltransferase genes (ST6GalNAc III and IV): characterization of their Sp1 binding sites. J Biochem 127:399–409
Tan S, Cheng PW (2007) Mucin biosynthesis: identification of the cis-regulatory elements of human C2GnT-M gene. Am J Respir Cell Mol Biol 36:737–745
Taniguchi A, Hasegawa Y, Higai K et al (2000) Transcriptional regulation of human beta-galactoside alpha2, 6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line. Glycobiology 10:623–628
Taniguchi A, Yoshikawa I, Matsumoto K (2001) Genomic structure and transcriptional regulation of human Galbeta1,3GalNAc alpha2,3-sialyltransferase (hST3Gal I) gene. Glycobiology 11:241–247
Taniguchi A, Saito K, Kubota T et al (2003a) Characterization of the promoter region of the human Galbeta1,3(4)GlcNAc alpha2,3-sialyltransferase III (hST3Gal III) gene. Biochim Biophys Acta 1626:92–96
Taniguchi A, Hioki M, Matsumoto K (2003b) Transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1, 4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene in testis and ovary cell lines. Biochem Biophys Res Commun 301:764–768
Taniuchi F, Higai K, Tanaka T et al (2013) Transcriptional regulation of fucosyltransferase 1 gene expression in colon cancer cells. TheScientificWorldJournal 2013:105464
Twu YC, Chen CP, Hsieh CY et al (2007) I branching formation in erythroid differentiation is regulated by transcription factor C/EBPalpha. Blood 110:4526–4534
Twu YC, Hsieh CY, Lin M et al (2010) Phosphorylation status of transcription factor C/EBPalpha determines cell-surface poly-LacNAc branching (I antigen) formation in erythropoiesis and granulopoiesis. Blood 115:2491–2499
Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97–130
Wei Y, Zhou F, Ge Y et al (2010) Regulation of the beta1,4-Galactosyltransferase I promoter by E2F1. J Biochem 148:263–271
Xu Q, Akama R, Isaji T et al (2011) Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation. J Biol Chem 286:4310–4318
Yoshida Y, Kurosawa N, Kanematsu T et al (1996) Genomic structure and promoter activity of the mouse polysialic acid synthase gene (mST8Sia II). Brain-specific expression from a TATA-less GC-rich sequence. J Biol Chem 271:30167–30173
Zhang W, Revers L, Pierce M et al (2000) Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors. Biochem J 347:511–518
Zhang XL, Qu XJ, Vijay IK (2003) STAT5a regulates the GlcNAc-1-phosphate transferase gene transcription and expression. Cell Physiol Biochem 13:85–92
Zhu X, Jiang J, Shen H et al (2005) Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. J Biol Chem 280:12503–12516
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this entry
Cite this entry
Guo, H., Pierce, J.M. (2015). Transcriptional Regulation of Glycan Expression. In: Taniguchi, N., Endo, T., Hart, G., Seeberger, P., Wong, CH. (eds) Glycoscience: Biology and Medicine. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54841-6_79
Download citation
DOI: https://doi.org/10.1007/978-4-431-54841-6_79
Received:
Accepted:
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54840-9
Online ISBN: 978-4-431-54841-6
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences